These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 508461)
81. The use of diazoxide in hypertension with renal damage. Pohl JE; Thurston H Clin Sci; 1971 Mar; 40(3):11P-12P. PubMed ID: 5550892 [No Abstract] [Full Text] [Related]
91. Hematological side-effects of diazoxide. Wales J; Wolff F Lancet; 1967 Jan; 1(7480):53-4. PubMed ID: 4163755 [No Abstract] [Full Text] [Related]
92. Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis. Langleben D; Orfanos S Pulm Circ; 2017; 7(3):588-597. PubMed ID: 28632001 [TBL] [Abstract][Full Text] [Related]
93. Detrimental effects of verapamil in patients with primary pulmonary hypertension. Packer M; Medina N; Yushak M; Wiener I Br Heart J; 1984 Jul; 52(1):106-11. PubMed ID: 6743418 [TBL] [Abstract][Full Text] [Related]
95. Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide. Chan NS; McLay J; Kenmure AC Br Heart J; 1987 Feb; 57(2):207-9. PubMed ID: 3814459 [TBL] [Abstract][Full Text] [Related]
96. Primary pulmonary hypertension. Higenbottam T Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1456-7. PubMed ID: 3099910 [No Abstract] [Full Text] [Related]
97. Drug treatment of primary pulmonary hypertension. McLeod AA; Jewitt DE Drugs; 1986 Feb; 31(2):177-84. PubMed ID: 2868878 [TBL] [Abstract][Full Text] [Related]